Issues regarding the use of human tissue in the drug development process
2026 · 1st Quarter (Jan 1 - Mar 31)
VIVOSIM LABS, INC.
Filed by TSG ADVOCATES DC, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- May 8, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- TSG ADVOCATES DC, LLC
- Client
- VIVOSIM LABS, INC.
- Filing UUID
- 04566293-d955-400f-9a52-5a4c5ac011ff
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.